09 Mar
Pharmaceutical Approval Update
Sitagliptin/Metformin drug HCl Tablets (Janumet)
Manufacturer: Merck, Inc., Whitehouse Station, NJ Indication: Sitagliptin/metformin HCl tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type-2 diabetes mellitus when glucose levels are not adequately controlled with generic metformin (Glucophage generic, Bristol-Myers Squibb) or sitagliptin (Januvia, Merck) alone or in [...]